Effects of Intravenous Disopyramide on Coronary Hemodynamics and Vasodilator Reserve in Hypertrophic Obstructive Cardiomyopathy

Cardiology (Switzerland)

Volumn 87, Issue 1, 1996, Pages 6-11

  Hongo, Minoru ^a   Ncikatsuka, Tatsuya ^a   Takenaka, Hiroaki ^a   Tanaka, Masao ^a   Watanabe, Noboru ^a   Yazaki, Yoshikazu ^a   Sekiguchi, Morie ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary hemodynamics; Coronary vasodilator reserve; Disopyramide; Hypertrophic obstructive cardiomyopathy

Indexed keywords

CORONARY VASODILATING AGENT; DISOPYRAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY HEMODYNAMICS; CORONARY VASCULAR RESISTANCE; DOPPLER FLOWMETRY; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; OXYGEN SUPPLY; PRIORITY JOURNAL; SPECTROSCOPY; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

EID: 0029655978     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177052     Document Type: Article

References (27)

1. Marrott PK, Rultley MST, Winterboltam JT. Muir JR: A study of the acute electrophysiolog-ical and cardiovascular actions of disopyram-ide in man. Eur J Cardiol 1976:4:303-312.
2. Pollick C. Giacomini KM. Blaschke TF. Nelson WL, Turner-Tamiyasu K, Briskin V, Popp RL: The cardiac effects of d-and l-disopyram-ide on normal subjects: A noninvasive study. Circulation 1982;66:447-453.
3. Pollick C: Muscular subaortic stenosis. Hemodynamic and clinical improvement after diso-pyramide. N Engl J Med 1982:307:997-999.
4. Sherrid M, Delia E, Dwvcr E: Oral disopyram-ide therapy for obstructive hypertrophic car-diomvopathy. Am J Cardiol 1988:62; 1085-1088.
5. Pollick C. Kimball B. Henderson M. Wigle ED: Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol 1988:62: 1248-1251.
6. Kötter V, Linderer T. Schröder R: Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: Comparison with lidocaine. Am J Cardiol 1980:46:469-475.
7. Wilson RF. Laughlin DE, Ackell PM. Chilian WM. Holida MD, Hartley CJ, Armstrong ML, Marcus ML. White CW: Transluminal, subscl-ective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation 1985;72:82-92.
8. Sibley DH, Millar HD, Hartley CJ, Whitlow PL: Subselective measurement of coronary blood flow velocity using a steerable Doppler catheter. J Am Coll Cardiol 1986:8:1 Hill 40.
9. Marcus ML, Wilson RF, White CW: Methods of measurement of myocardial blood flow in patients: A critical review. Circulation 1987; 76:245-253.
10. Rossen JD. Oskarsson H, Stenberg RG, Braun P. Talman CL. Winniford MD: Simultaneous measurement of coronary flow reserve by left anterior descending coronary artery Doppler and great cardiac vein thermodilution methods. J Am Coll Cardiol 1992:20:402-407.
11. Doucette JW. Corl PD. Payne HM. Flynn AE. Goto M, Nassi M, Segal J: Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-1911.
12. Johnson EL. Yock PG. Hargrave VK, Srcbro JP. Manubens SM, Seitz W, Ports TA: Assessment of severity of coronary stenoses using a Doppler catheter: Validation of a method based on the continuity equation. Circulation 1989:80:625-635.
13. Wilson RF, White CW: Intracoronary papaverine: An ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986;73:444-451.
14. Hongo M, Goto T. Watanabe N. Nakatsuka T, Tanaka M, Kinoshita O, Yamada H. Okubo S. Sekiguchi M: Relation of phasic coronary flow velocity profile to clinical and hemodynamic characteristics of patients with aortic valve disease. Circulation 1993;88:953-960.
15. Hongo M, Nakatsuka T. Watanabe N, Takena-ka H. Tanaka M. Kinoshita O, Okubo S, Sekiguchi M: Effects of heart rate on phasic coronary blood flow pattern and flow reserve in patients with normal coronary arteries: A study with an intravascular Doppler catheter and spectral analysis. Am Heart J 1994; 127:545-551.
16. Kimball BP. Bui S, Wigle ED: Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy. Am Heart J 1993;125:1691-1697.
17. Fifer MA, O'Gara RT, McGovern BA. Semi-gran MJ: Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol 1994;74:405-408.
18. Pollick C: Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration. Am J Cardiol 1988:62: 1252-1255.
19. Tomochika Y. Tanaka N. Wasaki Y. Shimizu H, Hiro J. Takahashi T. Tone T, Matsuzaki H. Okada K. Matsuzaki M: Assessment of flow profile of left anterior descending coronary artery in hypertrophic cardiomyopathy by transesophageal pulsed Doppler echocardiography. Am J Cardiol 1993;72:1425-1430.
20. Wilson RF: Assessment of the human coronary circulation using a Doppler catheter. Am J Cardiol 1991:67:44D-56D.
21. Nabel EG, Selwyn AP, Ganz P: Paradocixal narrowing of atherosclerotic coronary arteries induced by increases in heart rale. Circulation 1990;81:850-859.
22. McGinn AL. White CW, Wilson RF: Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure, and ventricular preload. Circulation 1990:81:1319-1330
23. Wilson RF. Wychc K, Christensen BV, Zimmer S, Laxon DD: Effects of adenosine on human coronary arterial circulation. Circulation 1990:82:1595-1606.
24. Hongo M. Takcnaka H, Uchikawa S, Nakatsuka T. Watanabe N, Sekiguchi M: Coronary microvascular response to intracoronary administration of nicrorandil. Am J Cardiol 1995;75:246-250.
25. Ohtsuka S, Kakihana M, Sugishita Y, Ito I: Effects of the rise in aortic pressure on coronary flow reserve in dogs. Jpn Heart J 1987:28:403-412.
26. Miyajima S. Aizawa Y. Matsuoka A, Okabe M. Shibata A: Danger of use of disopyramide in patients with hypertrophic obstructive cardiomyopathy. An electrophysiologic study. Jpn HearlJ 1988;29:115-119.
27. Millaire A. Goullard L. Dccoulx E, de Groote P, Houdas Y, Ducloux G: Efficiency of disopyramide in hypertrophic cardiomyopathy during stress states. Am J Cardiol 1992;69:423-424.